We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+15.94%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$33.8B
AUM Growth
+$4.19B
Cap. Flow
+$264M
Cap. Flow %
0.78%
Top 10 Hldgs %
21.76%
Holding
2,483
New
104
Increased
1,329
Reduced
987
Closed
53

Top Buys

Rank Stock Value
1
UL icon
Unilever
UL
+$52.4M
2
TSLA icon
Tesla
TSLA
+$42.1M
3
MSFT icon
Microsoft
MSFT
+$16.9M
4
DIS icon
Walt Disney
DIS
+$14.5M
5
MS icon
Morgan Stanley
MS
+$11.9M

Top Sells

Rank Stock Value
1
UN
Unilever NV New York Registry Shares
UN
+$48.8M
2
T icon
AT&T
T
+$25.4M
3
JNJ icon
Johnson & Johnson
JNJ
+$20M
4
AMZN icon
Amazon
AMZN
+$15.7M
5
BIIB icon
Biogen
BIIB
+$12.3M

Sector Composition

Rank Sector Weight
1 Technology 25.51%
2 Financials 13.6%
3 Healthcare 13.1%
4 Consumer Discretionary 11.54%
5 Communication Services 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDUS
2451
DELISTED
Radius Health, Inc.
RDUS
-10,715
Closed -$122K
VRS
2452
DELISTED
Verso Corporation
VRS
-30,474
Closed -$240K
CSLT
2453
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
-10,873
Closed -$12K
DSSI
2454
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
-18,390
Closed -$126K
TPCO
2455
DELISTED
Tribune Publishing Company Common Stock
TPCO
-16,568
Closed -$193K
TCO
2456
DELISTED
Taubman Centers Inc.
TCO
-50,958
Closed -$1.7M
HDS
2457
DELISTED
HD Supply Holdings, Inc.
HDS
-33,002
Closed -$1.36M
GLIBA
2458
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
-87,140
Closed -$7.14M
DNKN
2459
DELISTED
Dunkin' Brands Group, Inc.
DNKN
-66,528
Closed -$5.45M
BSTC
2460
DELISTED
BioSpecifics Technologies Corp.
BSTC
-3,988
Closed -$210K
MYOK
2461
DELISTED
MyoKardia, Inc. Common Stock
MYOK
-9,542
Closed -$1.3M
WMGI
2462
DELISTED
Wright Medical Group Inc
WMGI
-23,534
Closed -$719K
JCAP
2463
DELISTED
Jernigan Capital, Inc.
JCAP
-12,116
Closed -$208K
BITA
2464
DELISTED
Bitauto Holdings Limited
BITA
-15,780
Closed -$249K
ADSW
2465
DELISTED
Advanced Disposal Services Inc
ADSW
-46,151
Closed -$1.4M
LVGO
2466
DELISTED
Livongo Health, Inc. Common Stock
LVGO
-3,187
Closed -$446K
IMMU
2467
DELISTED
Immunomedics Inc
IMMU
-49,236
Closed -$4.19M
AIMT
2468
DELISTED
Aimmune Therapeutics
AIMT
-9,089
Closed -$313K
CETV
2469
DELISTED
Central European Media Enterprises Ltd
CETV
-26,092
Closed -$109K
AKCA
2470
DELISTED
Akcea Therapeutics Inc
AKCA
-17,934
Closed -$325K
VSLR
2471
DELISTED
VIVINT SOLAR, INC.
VSLR
-25,492
Closed -$1.08M
AMTD
2472
DELISTED
TD Ameritrade Holding Corp
AMTD
-135,352
Closed -$5.3M
NBL
2473
DELISTED
Noble Energy, Inc.
NBL
-415,561
Closed -$3.55M
ETFC
2474
DELISTED
E*Trade Financial Corporation
ETFC
-146,331
Closed -$7.32M
DLPH
2475
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
-25,895
Closed -$433K

Similar funds

Aperio Group's Q4 2020 Portfolio in Review

As of Q4 2020, Aperio Group held 2,483 positions worth $33.8B, up 14% from $29.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Aperio Group's Q4 2020 filing shows 104 new, 1,329 increased, 987 reduced and 53 closed positions. Its largest new stake was Concentrix: 51,604 shares worth $5.09M. The largest sale was Unilever NV New York Registry Shares, an estimated $48.8M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q4 2020 buy was Concentrix: 51,604 shares worth $5.09M.
  • Aperio Group added most to Unilever in Q4 2020, an estimated $52.4M increase.
  • Aperio Group's biggest Q4 2020 reduction was AT&T, cutting an estimated $25.4M.
  • Aperio Group fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $48.8M.
  • Aperio Group's ten largest holdings make up 22% of its $33.8B portfolio in Q4 2020.
  • Aperio Group opened 104 new positions and closed 53 in Q4 2020.
  • Aperio Group's portfolio value rose 14% quarter-over-quarter to $33.8B.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.